< Back to catalogue
Be Union
14 Ιουλίου, 2026Calcifolin®
15 Ιουλίου, 2026PHARMAZAC
Brivaracetam/Pharmazac
Brivaracetam | Antiepileptic | CNS
| BRIVARACETAM/PHARMAZAC F.C.TAB 10MG/TAB BTx14 |
| BRIVARACETAM/PHARMAZAC F.C.TAB 25MG/TAB BTx56 |
| BRIVARACETAM/PHARMAZAC F.C.TAB 50MG/TAB BTx56 |
| BRIVARACETAM/PHARMAZAC F.C.TAB 75MG/TAB BTx56 |
| BRIVARACETAM/PHARMAZAC F.C.TAB 100MG/TAB BTx56 |
| BRIVARACETAM/PHARMAZAC F.C.TAB 10MG/TAB BTx14 |
| BRIVARACETAM/PHARMAZAC F.C.TAB 25MG/TAB BTx56 |
| BRIVARACETAM/PHARMAZAC F.C.TAB 50MG/TAB BTx56 |
| BRIVARACETAM/PHARMAZAC F.C.TAB 75MG/TAB BTx56 |
| BRIVARACETAM/PHARMAZAC F.C.TAB 100MG/TAB BTx56 |
| ACTIVE SUBSTANCE | |
|---|---|
| BUSINESS UNIT | |
| MARKETING AUTHORISATION HOLDER | Pharmazac S.A. |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| THERAPEUTIC AREA |
